Cargando…
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
Glioblastoma (GBM) is associated with a very dismal prognosis, and current therapeutic options still retain an overall unsatisfactorily efficacy in clinical practice. Therefore, novel therapeutic approaches and effective medications are highly needed. Since the development of new drugs is an extreme...
Autores principales: | Persico, Michele, Abbruzzese, Claudia, Matteoni, Silvia, Matarrese, Paola, Campana, Anna Maria, Villani, Veronica, Pace, Andrea, Paggi, Marco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773942/ https://www.ncbi.nlm.nih.gov/pubmed/35053377 http://dx.doi.org/10.3390/cells11020263 |
Ejemplares similares
-
Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
por: Abbruzzese, Claudia, et al.
Publicado: (2020) -
Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021) -
Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017) -
Molecular Biology in Glioblastoma Multiforme Treatment
por: Abbruzzese, Claudia, et al.
Publicado: (2022) -
Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
por: Matteoni, Silvia, et al.
Publicado: (2021)